Abstract
There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
Translated title of the contribution | Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease |
---|---|
Original language | Spanish |
Pages (from-to) | 518-519 |
Number of pages | 2 |
Journal | Revista Chilena de Infectologia |
Volume | 34 |
Issue number | 5 |
DOIs | |
State | Published - Oct 2017 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018, Sociedad Chilena de Infectologia. All rights reserved.